Ann: Appointment of Managing Director, page-25

I note from the posts above that it appears that a pulse is all that is required from the new MD. I would have thought from scanning the various posts over the past few months that posters would want to see a new MD that has a positive track record.

As a HXG shareholder, I would have thought HLX shareholders would have seen the name of the new MD, done some pretty basic research and worked out that he's not the messiah you are all looking for. He's had 2 MD roles and failed in both of them.

Go back a while to his BSM days, a quick search of ASX announcements would show that he was dumped under a s249D cleanout of the Board with a scathing letter from the proposers before the vote - https://www.asx.com.au/asxpdf/20130916/pdf/42jcsks36tzmtb.pdf....a drop in share price from 49c to 1c in his last 2 years and blowing through over $50m in CR's.

Jump forward to his most recent role with HXG - he joined in 2017 when the mkt cap was $56.6 million. When he just announced he was leaving (just after the Chairman pre-empted it at the AGM), HXG's market cap was $16.7 million, a drop of 71%. During his reign as MD, the company has had FOUR different commodity strategies in THREE years - graphite, rare earth processing, gold and now hydrogen. Have a look at the reaction here on HC to his departure - there is no love lost at all.

I am not a HLX shareholder and based on the pain of being a HXG shareholder, with flip-flopping strategies, no share price, market or media traction and a lack of market communication skills, I have no plans to be.